Research advances in biomaterials with promising in vivo results have opened new perspectives in the development of cartilage repair methodologies, but the advantages of these new strategies when compared with established cartilage repair and regeneration techniques is not yet well established in clinics. Long term follow up and more comparative systematic trials are required to establish the best method for cartilage regeneration. Also, in tissue engineering the regulatory process is vital, and one of the first aspects considered in the development of new strategies in general and in biomaterial platforms in particular. The increasing number of product development for cartilage repair and regeneration reflects the interest and technological advances in the field. Advances in basic research for cartilage repair leads to improved clinical therapies, however their success depends on their capability to simplifying the surgical procedures and to enhance the tissue regeneration. Only the well-designed prospective clinical studies will dictate the survival of a novel therapy by validating and comparing its efficacy to existing therapies and will allow overcoming the regulation process. However, cartilage regeneration still remains deficient to some extent and its market still is to be conquered.
Regionally, North America is the leading market for cartilage repair and regeneration procedures. The rising number of road accidents, dominance of degenerative lifestyle conditions and easy availability of advanced cartilage repair and regeneration facilities have driven the North American cartilage regeneration market. Also strong healthcare research and development framework in North America is likely to result in the production of increasingly cost-effective and more efficient cartilage regeneration procedures in coming years, which is ensuring steady growth of this region. On the other hand, Asia Pacific in the global cartilage regeneration market is likely to expand robustly. While the Europe market for cartilage regeneration is likely to hold a higher valuation than Asia Pacific.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/14704
Some of the players in the cartilage regeneration market B. Braun Melsungen AG, DePuy Synthes, Geistlich Holding, Osiris Therapeutics, Inc., Smith & Nephew plc, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc. Players of cartilage regeneration market are shifting focus on gaining a strong position in the emerging economies. Factors such as strong local manufacturing base and rapidly developing health care infrastructure in emerging countries has encouraged global players to adopt various cost-effective strategies in order to gain a strong foothold in these regions.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/14704